Sale!

ZSWIM6 Gene Acromelic Frontonasal Dysostosis Genetic Test

Name: ZSWIM6 Gene Acromelic Frontonasal Dysostosis Genetic Test
SKU: TEST-3973
Price: 4400 AED
Availability: InStock

4,400 د.إ

-21%

The ZSWIM6 gene is implicated in a rare genetic disorder known as acromelic frontonasal dysostosis. This condition is characterized by distinctive facial features, limb abnormalities, and other developmental anomalies. Given the rarity and complexity of this disorder, genetic testing for mutations in the ZSWIM6 gene is crucial for accurate diagnosis and management.

DNA Labs UAE offers a specialized genetic test targeting the ZSWIM6 gene to diagnose acromelic frontonasal dysostasis. This test is a vital tool for clinicians and genetic counselors, enabling them to understand the genetic underpinnings of the disorder in affected individuals. Through a detailed analysis of the ZSWIM6 gene, the test can identify specific mutations that cause the condition, providing essential information for diagnosis, treatment planning, and genetic counseling.

The cost of the ZSWIM6 Gene Acromelic Frontonasal Dysostosis Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the technical processes of extracting DNA, analyzing the specific gene sequences, and interpreting the results to provide a comprehensive report. Given the specialized nature of this test and the expertise required to interpret its results, the cost reflects the high level of precision and care provided by DNA Labs UAE in assisting families and individuals in navigating the complexities of genetic disorders.

Description

ZSWIM6 Gene Acromelic Frontonasal Dysostosis Genetic Test

Test Name: ZSWIM6 Gene Acromelic Frontonasal Dysostosis Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Dysmorphology

Doctor: Pediatrics

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for ZSWIM6 Gene Acromelic Frontonasal Dysostosis NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ZSWIM6 Gene Acromelic Frontonasal Dysostosis NGS Genetic DNA Test gene ZSWIM6

Test Details: The ZSWIM6 gene is associated with a condition called acromelic frontonasal dysostosis. Acromelic frontonasal dysostosis is a rare genetic disorder characterized by abnormalities in the development of the face, hands, and feet. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. This type of testing can be used to identify mutations or variations in the ZSWIM6 gene or other genes associated with acromelic frontonasal dysostosis. By analyzing the DNA sequence of the ZSWIM6 gene, NGS genetic testing can help diagnose individuals with acromelic frontonasal dysostosis and provide information about the specific genetic changes causing the condition. This information can be useful for understanding the underlying cause of the disorder, predicting disease progression, and guiding treatment options.

Test Name	ZSWIM6 Gene Acromelic frontonasal dysostosis Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Dysmorphology
Doctor	Pediatrics
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for ZSWIM6 Gene Acromelic frontonasal dysostosis NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ZSWIM6 Gene Acromelic frontonasal dysostosis NGS Genetic DNA Test gene ZSWIM6
Test Details	The ZSWIM6 gene is associated with a condition called acromelic frontonasal dysostosis. Acromelic frontonasal dysostosis is a rare genetic disorder characterized by abnormalities in the development of the face, hands, and feet. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. This type of testing can be used to identify mutations or variations in the ZSWIM6 gene or other genes associated with acromelic frontonasal dysostosis. By analyzing the DNA sequence of the ZSWIM6 gene, NGS genetic testing can help diagnose individuals with acromelic frontonasal dysostosis and provide information about the specific genetic changes causing the condition. This information can be useful for understanding the underlying cause of the disorder, predicting disease progression, and guiding treatment options.